http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2036547-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f65418655c62cdfeecde1ce087e8acbb
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D319-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-14
filingDate 2002-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf87c5d161d0217f6947bfedd5cc0923
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c8692b6cd4c09a23fe51e5ca1c522aad
publicationDate 2009-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2036547-A3
titleOfInvention Treatment for Attention-Deficit Hyperactivity Disorder
abstract A solid dosage form comprising eltoprazine or pharmaceutically acceptable salt thereof for treating Attention Deficit/Hyperactivity Disorder (ADHD) in humans and the symptoms associated therewith, inattentiveness, and hyperactivity with impulsivity.
priorityDate 2001-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226538723
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129640067
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65853
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425936615

Total number of triples: 33.